OncoTherapy Science: Announcements of individual stocks: Publication of paper on the results of phase III clinical trial of S-588410 targeting esophageal cancer patients.

JPX · Jul 30 07:30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.